BioWorld Asia

Jan. 28, 2004

Two German Kinase Companies Merge, Bring In EUR11M Financing

MUNICH, Germany - Two young Munich biotechnology companies - Nadag AG and Sireen AG - merged to form Sirenade Pharmaceuticals AG, which will focus on oncology and central nervous system conditions. (BioWorld International) Read More

As GW's Sativex Is Reviewed, Extension-Study Data Grow

Detailed Inflammation Pathway Map To Hasten Drug Discovery

BresaGen Seeking Protection After Talks With Investor Fail

Denmark Eyes North Sea Oil Tax As Source For Research Funding

EU Aiming To Pave Way For Tissue-Engineering Market

Other News To Note

NIH changes set industry up for workforce, ideas drought

BioWorld

On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...

Today's news in brief

BioWorld

BioWorld briefs for March 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for March 12, 2025

At CROI, HIV cure trials raise hopes for broader applicability

BioWorld

At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...

Hummingbird migrates ADCs, tech to newco Callio’s $187M debut

BioWorld

Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...